By integrating the TM9SF4 expression with clinicopathological characteristics, we developed and validated a nomogram, which improved the prediction of the HCC prognosis compared to the clinicopathological characteristics alone. The gene discussed is TM9SF4; the disease is hepatocellular carcinoma.